Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on STEM Minnesota.

BridgeBio to Present Additional Cardiovascular Outcomes Data from ATTRibute-CM at the HFSA Annual Scientific Meeting 2025
PALO ALTO, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced today that one late breaking clinical trials...

Combatting the EPA’s Ongoing Assault on Climate Science: Attorney General Bonta Slams EPA’s Proposed Rescission of Endangerment Finding
Through multiple actions, Attorney General Bonta and multistate partners, stand up for climate science, oppose EPA’s proposal to repeal all the federal motor vehicle greenhouse gas emission standards that protect the health and safety of Americans...

Hairmax Celebrates 25 Years of Innovation in Hair Growth Technology
From the first FDA-cleared laser hair growth device to a global portfolio of devices and hair care, Hairmax continues to lead the laser hair growth industry. BOCA RATON, FL, UNITED STATES, September 22, 2025 /EINPresswire.com/ -- Hairmax...

Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders
MINNEAPOLIS and BRISBANE, Australia, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR), a global structural heart company committed to designing, developing, and commercializing...

Cytokinetics Announces Three Upcoming Presentations at the HFSA Annual Scientific Meeting 2025
Long-Term Data from FOREST-HCM in Non-Obstructive HCM and Results from Prespecified Analysis of MAPLE-HCM to be Presented in Late-Breaking Clinical Research Session SOUTH SAN FRANCISCO, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Cytokinetics,...

A First-of-Its-Kind Non-Surgical Procedure is Now in Clinical Trials
MINNEAPOLIS, MN, UNITED STATES, October 10, 2025 /EINPresswire.com/ -- Type 2 diabetes is one of the most significant health challenges in the U.S., affecting more than 34 million Americans — with nearly 9 million undiagnosed. Left unmanaged,...

Inspire Medical Systems, Inc. Publishes Inspire V Data at ISSS/AAO-HNS Meetings
MINNEAPOLIS, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with...

Long Life Family Study Taps PacBio HiFi Sequencing to Unlock Genetic and Epigenetic Clues to Exceptional Longevity
MENLO PARK, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate long-read sequencing solutions, today announced that the National Institute on Aging’s Long Life Family Study (LLFS)...
SEALSQ and Trusted Semiconductor Solutions Partner to Develop “Made in US” Post-Quantum Secure Solutions for US Government and Defense Agencies
Geneva, Switzerland; Brooklyn Park, Minnesota, USA, Oct. 09, 2025 (GLOBE NEWSWIRE) -- October 9, 2025 – SEALSQ Corp (NASDAQ: LAES), a global leader in semiconductors and Post-Quantum Cryptography (PQC) solutions, and Trusted Semiconductor...

Amivie Expands In-Home Care Services with Acquisitions of Atrio Home Health and Rent A Daughter
RESEARCH TRIANGLE PARK, NC, UNITED STATES, October 8, 2025 /EINPresswire.com/ -- Amivie, a leading provider of home and community-based services across six states, today announced two strategic acquisitions: Atrio Home Health, a Minnesota-based...

Dayforce Expands Collaboration with Microsoft to Transform HCM Workflows With AI
MINNEAPOLIS and TORONTO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Dayforce, Inc. (NYSE: DAY; TSX: DAY), a global leader that makes work life better, today announced an expansion of its collaboration with Microsoft to bring Dayforce AI Agents into...



Dayforce Introduces New Dayforce AI Agents to Accelerate How Work Gets Done
MINNEAPOLIS and TORONTO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Dayforce, Inc. (NYSE: DAY; TSX: DAY), a global human capital management (HCM) leader that makes work life better, today announced the next generation of Dayforce AI Agents. Purpose-built...

16th Annual Dayforce Pulse of Talent: 71% of Workers Untrained in AI as Adoption and Expectations Surge
MINNEAPOLIS and TORONTO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Dayforce, Inc. (NYSE: DAY; TSX: DAY), a global human capital management (HCM) leader that makes work life better, today released findings from its 16th Annual Pulse of Talent report. The...

Dayforce Expands Dayforce Partner Network to Power Global Growth and Deliver More Value to Customers, Faster
MINNEAPOLIS and TORONTO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Dayforce, Inc. (NYSE: DAY; TSX: DAY), a global human capital management (HCM) leader that makes work life better, today announced significant enhancements to its Dayforce Partner Network...

American Rebel Holdings, Inc. (NASDAQ: AREB) to Showcase America’s Patriotic Beer - American Rebel Light at the Annual 2025 National Beer Wholesalers Association (NBWA) Convention in Las Vegas, Nevada
Hall of Famer Driver Tony Stewart to Join American Rebel Light Beer Team October 13–14 for Distributor Engagement and American Rebel Brand Activation at Booth 620 NHRA Top Fuel Driver and TSR Nitro Owner to Represent American Rebel Light Beer in...

Neology Successfully Completes E-ZPass Back-Office System and Customer Support Center Service Transition for MnDOT
Minnesota Department of Transportation Adopts Scalable, Secure Tolling Technology with Advanced neoBOSS™ Platform Solution CARLSBAD, CA, UNITED STATES, October 6, 2025 /EINPresswire.com/ -- Neology, a global transportation technology company...

AMS to Host CLE Seminar on 'Contemporary Issues in Music & Copyright Law'
The event is organized in partnership with the Minnesota Bar Association. NEW YORK, NY, UNITED STATES, October 8, 2025 /EINPresswire.com/ -- The American Musicological Society (AMS), in collaboration with the Sports, Art & Entertainment Law...
GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies
The Company is well on track with Phase 1 enrollment now that both patients in Cohort 3 have successfully initiated treatment with no evidence of dose-limiting toxicities or tolerability concerns to date The first patient in Cohort 3 has shown...